These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21078296)

  • 1. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death.
    Becker KA; Tümmler B; Gulbins E; Grassmé H
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):368-74. PubMed ID: 21078296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
    Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
    Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
    Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide in cystic fibrosis.
    Grassmé H; Riethmüller J; Gulbins E
    Handb Exp Pharmacol; 2013; (216):265-74. PubMed ID: 23563661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipids in cystic fibrosis.
    Becker KA; Henry B; Ziobro R; Riethmüller J; Gulbins E
    Expert Rev Respir Med; 2011 Aug; 5(4):527-35. PubMed ID: 21859272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis.
    Becker KA; Grassmé H; Zhang Y; Gulbins E
    Cell Physiol Biochem; 2010; 26(1):57-66. PubMed ID: 20502005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa.
    Grassmé H; Becker KA; Zhang Y; Gulbins E
    Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the inflammasome by ceramide in cystic fibrosis lungs.
    Grassmé H; Carpinteiro A; Edwards MJ; Gulbins E; Becker KA
    Cell Physiol Biochem; 2014; 34(1):45-55. PubMed ID: 24977480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective regulatory volume decrease in human cystic fibrosis tracheal cells because of altered regulation of intermediate conductance Ca2+-dependent potassium channels.
    Vázquez E; Nobles M; Valverde MA
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5329-34. PubMed ID: 11309505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide in bacterial infections and cystic fibrosis.
    Grassmé H; Becker KA; Zhang Y; Gulbins E
    Biol Chem; 2008 Nov; 389(11):1371-9. PubMed ID: 18783339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide mediates lung fibrosis in cystic fibrosis.
    Ziobro R; Henry B; Edwards MJ; Lentsch AB; Gulbins E
    Biochem Biophys Res Commun; 2013 May; 434(4):705-9. PubMed ID: 23523785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
    Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine.
    De Lisle RC; Roach E; Jansson K
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G577-84. PubMed ID: 17615175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis.
    Becker KA; Riethmüller J; Zhang Y; Gulbins E
    Open Respir Med J; 2010 Mar; 4():39-47. PubMed ID: 20556203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of IL-8 release from CFTR-deficient lung epithelial cells following pre-treatment with fenretinide.
    Vilela RM; Lands LC; Meehan B; Kubow S
    Int Immunopharmacol; 2006 Nov; 6(11):1651-64. PubMed ID: 16979119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant natural killer T (iNKT) cells prevent autoimmunity, but induce pulmonary inflammation in cystic fibrosis.
    Siegmann N; Worbs D; Effinger F; Bormann T; Gebhardt M; Ulrich M; Wermeling F; Müller-Hermelink E; Biedermann T; Tighe M; Edwards MJ; Caldwell C; Leadbetter E; Karlsson MC; Becker KA; Gulbins E; Döring G
    Cell Physiol Biochem; 2014; 34(1):56-70. PubMed ID: 24977481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model.
    Haston CK; Cory S; Lafontaine L; Dorion G; Hallett MT
    Physiol Genomics; 2006 Apr; 25(2):336-45. PubMed ID: 16614460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
    Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
    Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model.
    Cohen JC; Morrow SL; Cork RJ; Delcarpio JB; Larson JE
    Mol Genet Metab; 1998 Jun; 64(2):108-18. PubMed ID: 9705235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.